Everardo Cobos to Humans
This is a "connection" page, showing publications Everardo Cobos has written about Humans.
Connection Strength
0.531
-
Loayza Pintado J, Ajani T, Hernandez D, Cobos E. A Rare Culprit or an Elusive Culprit in Disguise? Unraveling Wild-Type ATTR Cardiac Amyloidosis in Heart Failure With Reduced Ejection Fraction. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251345712.
Score: 0.042
-
Cobos E, Goldis G, McCallum R. 'Wisdom in the time of COVID-19'. J Investig Med. 2021 02; 69(2):305-306.
Score: 0.031
-
Farmand D, Valdez MC, Moosavi L, Cobos E. Locus Minoris Resistentiae: Two Cases of Malignant Metastasis and Review of Literature. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:2324709621997248.
Score: 0.031
-
Jariwal R, Raza N, Bhandohal J, Cobos E. Non-Hodgkin's Plasmablastic Lymphoma as Initial Presentation of Human Immunodeficiency Virus. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:23247096211014689.
Score: 0.031
-
Sharma R, Johnson RH, Heidari A, Malerich M, Stull WR, Cobos E. Neutrophilic Dermatosis in Myelodysplastic Syndrome and Chronic Active Hepatitis C. J Investig Med High Impact Case Rep. 2021 Jan-Dec; 9:23247096211037458.
Score: 0.031
-
Civelli VF, Narang VK, Sharma R, Sharma R, Kim J, Bhandohal J, Moosavi L, Cobos E. A Progressive Case of Eosinophilic Myocarditis Due to Eosinophilic Granulomatosis With Polyangiitis in a Caucasian Male. J Investig Med High Impact Case Rep. 2020 Jan-Dec; 8:2324709620966855.
Score: 0.029
-
Moosavi L, Kim P, Uche A, Cobos E. A Synchronous Diagnosis of Metastatic Male Breast Cancer and Prostate Cancer. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619847230.
Score: 0.027
-
Delgado BJ, Moosavi L, Rangel E, Stull W, Polineni RD, Chen J, Cobos E. An Unusual Presentation of Spinal Giant Cell Glioblastoma in a 21-Year-Old Female. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619868255.
Score: 0.027
-
Moosavi L, D'Assumpcao C, Bowen J, Heidari A, Cobos E. Leptomeningeal Carcinomatosis From Carcinoma of Unknown Primary in a Young Patient: A Case Report and a Literature Review. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619869380.
Score: 0.027
-
Moosavi L, Bowen J, Coleman J, Heidari A, Cobos E. Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619872657.
Score: 0.027
-
Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, Jenkins M, Chiriva-Internati M, Cobos E. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol. 2014 Oct; 33(5):383-401.
Score: 0.020
-
Chiriva-Internati M, Mirandola L, Yu Y, Jenkins MR, Gornati R, Bernardini G, Gioia M, Chiaramonte R, Cannon MJ, Kast WM, Cobos E. Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy. J Immunother. 2011 Jul-Aug; 34(6):490-9.
Score: 0.016
-
Li W, Frame LT, Hirsch S, Cobos E. Genistein and hematological malignancies. Cancer Lett. 2010 Oct 01; 296(1):1-8.
Score: 0.015
-
Chiriva-Internati M, Ferrari R, Prabhakar M, Yu Y, Baggoni L, Moreno J, Gagliano N, Portinaro N, Jenkins MR, Frezza EE, Hardwicke F, D'Cunha N, Kast W, Cobos E. The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma. J Transl Med. 2008 Apr 02; 6:15.
Score: 0.013
-
Othon-Mart?nez D, Fernandez-Betances OA, M?laga-Espinoza BX, Torres-Perez ME, Cobos E, Gutierrez-Martinez C. Iron and cardiovascular health: A review. J Investig Med. 2024 12; 72(8):787-797.
Score: 0.010
-
Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S, Cobos E, Yallapu MM, Jaggi M, Chauhan SC. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. Cancer Metastasis Rev. 2024 Sep; 43(3):981-999.
Score: 0.010
-
Govindarajan A, Venter F, Chaudhry A, Kaur H, Cobos E, Petersen G. Colorectal Carcinoma-An Anomalous Trigger of Adult Hemophagocytic Lymphohistiocytosis. J Investig Med High Impact Case Rep. 2024 Jan-Dec; 12:23247096241273131.
Score: 0.010
-
Dhasmana A, Dhasmana S, Haque S, Cobos E, Yallapu MM, Chauhan SC. Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics. Cancer Metastasis Rev. 2023 09; 42(3):597-600.
Score: 0.009
-
Govindarajan A, Sous R, Venter F, Torrico T, Karapetians N, Heidari A, Cobos E, Petersen G. A Case of Disseminated Histoplasmosis From California, in the Setting of Secondary Hemophagocytic Lymphohistiocytosis: A Diagnostic Challenge. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231156007.
Score: 0.009
-
Hajeh H, Aboaid H, Fox K, Cobos E, Heidari A. What You See Is Not What You Get: Germ Cell Tumor Mimicking Disseminated Coccidioidomycosis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231191872.
Score: 0.009
-
Mann BK, D'Assumpcao C, Okumoto L, Aboaid S, Abooed A, Cobos E, Heidari A. Spurious Presentation of Pulmonary Kaposi Sarcoma as Unresolved Pneumonia Led to Fatal Outcome. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231208996.
Score: 0.009
-
Sharma R, Heidari A, Cobos E, Petersen G, Ramzan AA, Polineni RD. Two Cases of Pelvic Diffuse Large B-Cell Lymphoma. J Investig Med High Impact Case Rep. 2022 Jan-Dec; 10:23247096221089505.
Score: 0.008
-
Mann BK, Bhandohal JS, Cobos E, Chitturi C, Eppanapally S. LECT-2 amyloidosis: what do we know? J Investig Med. 2022 02; 70(2):348-353.
Score: 0.008
-
Thomas JS, El-Khoueiry AB, Maurer BJ, Groshen S, Pinski JK, Cobos E, Gandara DR, Lenz HJ, Kang MH, Reynolds CP, Newman EM. A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors. Cancer Chemother Pharmacol. 2021 04; 87(4):525-532.
Score: 0.008
-
Mirandola L, Figueroa JA, Phan TT, Grizzi F, Kim M, Rahman RL, Jenkins MR, Cobos E, Jumper C, Alalawi R, Chiriva-Internati M. Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets. Oncotarget. 2015 Feb 20; 6(5):2812-26.
Score: 0.005
-
Mirandola L, Yu Y, Cannon MJ, Jenkins MR, Rahman RL, Nguyen DD, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M. Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer. Gynecol Oncol. 2014 Dec; 135(3):573-9.
Score: 0.005
-
Mirandola L, Nguyen DD, Rahman RL, Grizzi F, Yuefei Y, Figueroa JA, Jenkins MR, Cobos E, Chiriva-Internati M. Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer? Int Rev Immunol. 2014 Oct; 33(5):417-27.
Score: 0.005
-
Zhu H, Cao M, Mirandola L, Figueroa JA, Cobos E, Chiriva-Internati M, Hermonat PL. Comparison of efficacy of the disease-specific LOX1- and constitutive cytomegalovirus-promoters in expressing interleukin 10 through adeno-associated virus 2/8 delivery in atherosclerotic mice. PLoS One. 2014; 9(4):e94665.
Score: 0.005
-
Absar S, Choi S, Ahsan F, Cobos E, Yang VC, Kwon YM. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. Thromb Res. 2013 Mar; 131(3):e91-9.
Score: 0.004
-
Pandey A, Kurup A, Shrivastava A, Radhi S, Nguyen DD, Arentz C, D'Chuna N, Hardwick F, D'Souza MJ, Jenkins M, Grizzi F, Kast WM, Cobos E, Rahman R, Chiriva-Internati M, Chiaramonte R, Platonova N. Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability. Int Rev Immunol. 2012 Oct; 31(5):302-20.
Score: 0.004
-
Chiriva-Internati M, Pandey A, Saba R, Kim M, Saadeh C, Lukman T, Chiaramonte R, Jenkins M, Cobos E, Jumper C, Alalawi R. Cancer testis antigens: a novel target in lung cancer. Int Rev Immunol. 2012 Oct; 31(5):321-43.
Score: 0.004
-
Schutt C, Bumm K, Mirandola L, Bernardini G, Cunha N, Tijani L, Nguyen D, Cordero J, Jenkins MR, Cobos E, Kast WM, Chiriva-Internati M. Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma. Int Rev Immunol. 2012 Feb; 31(1):22-42.
Score: 0.004
-
Kim M, Mirandola L, Pandey A, Nguyen DD, Jenkins MR, Turcel M, Cobos E, Chiriva-Internati M. Application of vitamin D and derivatives in hematological malignancies. Cancer Lett. 2012 Jun 01; 319(1):8-22.
Score: 0.004
-
Mirandola L, Yu Y, Jenkins MR, Chiaramonte R, Cobos E, John CM, Chiriva-Internati M. Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer. 2011 Sep 16; 11:394.
Score: 0.004
-
Chiriva-Internati M, Mirandola L, Kast WM, Jenkins MR, Cobos E, Cannon MJ. Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies. Int Rev Immunol. 2011 Apr-Jun; 30(2-3):71-86.
Score: 0.004
-
Yu Y, Pilgrim P, Yan J, Zhou W, Jenkins M, Gagliano N, Bumm K, Cannon M, Milzani A, Dalle-Donne I, Kast WM, Cobos E, Chiriva-Internati M. Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells. J Transl Med. 2008 Oct 05; 6:56.
Score: 0.003
-
Chiriva-Internati M, Weidanz JA, Yu Y, Frezza EE, Jenkins MR, Kennedy RC, Cobos E, Kast WM. Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer. J Immunother. 2008 Oct; 31(8):693-703.
Score: 0.003
-
Chiriva-Internati M, Cobos E, Da Silva DM, Kast WM. Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun. 2008 Apr 24; 8:8.
Score: 0.003
-
Chiriva-Internati M, Grizzi F, Wachtel MS, Jenkins M, Ferrari R, Cobos E, Frezza EE. Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci. 2008 Mar; 53(3):836-43.
Score: 0.003
-
Chiriva-Internati M, Cobos E, Kast WM. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials. Int Rev Immunol. 2007 May-Aug; 26(3-4):197-222.
Score: 0.003
-
Chiriva-Internati M, Grizzi F, Weidanz JA, Ferrari R, Yuefei Y, Velez B, Shearer MH, Lowe DB, Frezza EE, Cobos E, Kast WM, Kennedy RC. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods. 2007 Apr 10; 321(1-2):86-93.
Score: 0.003
-
Chiriva-Internati M, Grizzi F, Jumper CA, Cobos E, Hermonat PL, Frezza EE. Immunological treatment of liver tumors. World J Gastroenterol. 2005 Nov 14; 11(42):6571-6.
Score: 0.003
-
Jumper C, Cobos E, Lox C. Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med. 2004 Feb; 98(2):173-7.
Score: 0.002